עיבוד של semiautomated מחזור תא גידול מבחני (CTC) ליישומים קליניים ומחקר הקליני

Overview

This study focuses on the detection, enumeration, and characterization of circulating tumor cells (CTCs) from human and mouse xenograft blood samples. It highlights the use of the CellSearch system for CTC analysis and describes protocols for user-defined marker characterization.

Key Study Components

Area of Science

• Oncology
• Cell Biology
• Translational Research

Background

• Circulating tumor cells (CTCs) serve as prognostic indicators in metastatic cancers.
• The CellSearch system is the gold standard for CTC enumeration.
• Common misclassification errors in CTC analysis are addressed.
• Protocols for CTC characterization in preclinical models are developed.

Purpose of Study

• To enhance the sensitivity of CTC detection and enumeration.
• To characterize CTCs for better targeted therapy selection.
• To validate the CellSearch system in both human and mouse models.

Methods Used

• Collection of blood samples from human and mouse cancer models.
• Positive selection for epca positive cells to enrich for CTCs.
• Differential staining to identify and enumerate CTCs.
• Molecular characterization of CTCs to inform therapy choices.

Main Results

• CTCs were successfully detected and enumerated in both human and mouse samples.
• The CellSearch system demonstrated effective CTC analysis.
• User-defined protocols for CTC characterization were developed.
• Results support the potential for improved targeted therapy selection.

Conclusions

• The study confirms the efficacy of the CellSearch system for CTC analysis.
• Adapted protocols may enhance CTC characterization for clinical applications.
• Further development of these methods could aid in personalized cancer therapy.

Frequently Asked Questions